Tuesday, August 3, 2021
Home Breaking News Immune Therapeutics Inc. Spinoff Cytocom, Inc. to Participate in Biotech Showcase and...

Immune Therapeutics Inc. Spinoff Cytocom, Inc. to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During “J.P. Morgan Week 2021”

WINTER PARK, FL, Jan. 11, 2021 (GLOBE NEWSWIRE) — Immune Therapeutics, Inc. (Ticker: IMUN) announced today that Cytocom, Inc., a company that spun-off from Immune in 2014, is participating in Biotech Showcase Digital and H.C. Wainwright BioConnect. Both events will be held virtually and are scheduled alongside the J.P. Morgan 39th Annual Healthcare Conference 2021.

Details of the events are as follows:
Biotech Showcase Digital
Date:Â January 11-15, 2021
Registration: https://informaconnect.com/biotech-showcase/registration-options/

H.C. Wainwright BioConnect 2021 Conference
Date: January 11-14, 2021
Registration: https://hcwevents.com/bioconnect/#

For more information on Cytocom and their participation in these please go to their website at www.Cytocom.com.

Immune Therapeutics:(888) 613-8802 www.immunetherapeutics.com

Most Popular

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient Centric...

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording &...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording...

Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings

Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin(R) line of pain relief...

Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and anti-inflammatory drugs

Advertisement

Subscribe to our Stock News Alerts

Mobile is not required however if you want the fastest
delivery be sure to add your mobile.

Subscribe to our News Alerts
Loading